All Posts: cancer research

108 Articles

GUMC Stories

With a New ‘Map’ of Cells, Georgetown Cancer Researchers Chart a Course to More Effective Treatment

Faculty and students from Biomedical Graduate Education programs, the School of Medicine and Lombardi Comprehensive Cancer Center are developing a new technique that could…

January 14, 2025

GUMC Stories

Months After Chemotherapy, MD/PhD Student Bikes 50 Miles for Cancer Research

A year and a half into medical school at Georgetown, Bryan Weselman was diagnosed with cancer. Now, he's researching cancer to improve treatment for other.…

November 1, 2024

GUMC Stories

For This Medical Student, Her Cancer Research Is for Her Little Sister

Ritu Amarnani (M’27), a second-year medical student, spent this summer researching cancer care at Georgetown’s Lombardi Comprehensive Cancer Center. She turned her career…

August 22, 2024

GUMC Stories

Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer?

For the first time, new research by Georgetown scientists shows potential to make immunotherapy effective in pancreatic cancer by combining it with a drug that makes cancer cells…

February 2, 2024

GUMC Stories

Understanding Immunotherapy Resistance Leads to New Therapeutic Strategies — and Hope

Samir Khleif, MD, an immunologist and professor of oncology at Georgetown Lombardi, is working to understand why some cancers become resistant to immunotherapy, and how that…

January 18, 2024

GUMC Stories

Ruesch Center Symposium Focuses on Early-Onset GI Cancer

With an emphasis on early-onset gastrointestinal cancer, the 14th Annual Ruesch Center Symposium brought together nearly 300 health care providers, researchers, advocates,…

November 22, 2023

GUMC Stories

Lombardi Women Event Rallies Support for Breast Cancer Research

The 17th Annual Lombardi Women event brought together nearly 400 of the Washington area’s most influential women in support of Georgetown University’s Lombardi Comprehensive…

October 19, 2023

News Release

Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer Uncovered

How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to…

July 17, 2023

News Release

Researchers Develop Method to Monitor Cancer Radiotherapy Effects at the Cellular Level

Using complex molecular tools, Georgetown Lombardi researchers have determined how to measure, in real time, the effect that radiation treatment for cancer can have at the…

June 20, 2023

News Release

Novel Research Shows Older Breast Cancer Survivors Experience Accelerated Aging, Worse Functional Outcomes

In a new multicenter study, researchers from Georgetown University’s Lombardi Comprehensive Cancer Center, the Medical College of Wisconsin (MCW), UCLA and several other…

June 15, 2023